EFFECTS OF PERINDOPRIL INITIATION ON SERUM CREATININE AND POTASSIUM LEVELS FOLLOWING ACUTE CORONARY SYNDROME (ACS)
Keywords:
Abstract
Perindopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed as a cardioprotective medication following acute coronary syndrome (ACS). However, concerns have been raised regarding its potential impact on renal function and serum potassium levels. This study aimed to investigate the effects of perindopril initiation on serum creatinine and potassium levels in patients with ACS.
Similar Articles
-
Microbiocenosis Of Open Cavities Of The Body
-
ASSESMENT OF YOUTH REPRODUCTIVE HEALTH SERVICE PREFERENCES, ARAB BORDADE HEALTH CENTER GUMBI BORDERED WOREDA WEST HARARGHE, OROMIA REGION, ETHIOPIA
The American Journal of Medical Sciences and Pharmaceutical Research: No. 05 (2022) / Jegnaw Zenebe Gizaw, Salah, Amanuel, -
ANALYSIS OF THE THYROID STATUS OF PREGNANT WOMEN IN THE IODINE-DEFICIENT REGION
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2022) / Negmatova Gulzoda Shukhratovna, Togaeva Gulnora Siddiqovna, Davranova Aziza Davranovna, Azimbegova Sitora Nodirovna, -
COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF TRADITIONAL AND INTERACTIVE TEACHING METHODS IN POSTGRADUATE EDUCATION IN DENTISTRY
-
Formation Of Young People Of The Younger Generation In Uzbekistan As A Science-Driven Process
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Yu.M. Khalimbetov, Yuldashev S.J , Murodova U.R, -
Emergency Preparedness and Innovative Response Plan for Smooth Congregations during COVID-19 pandemic: An Urgent Need for Comprehensive Approaches to Tactically Resolve Risk of SARS-CoV-2 or MERS-CoV Transmission
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2021) / Umar Saeed , Zahra Zahid Piracha , Sara Rizwan Uppal , Muhammad Saad Uppal , Aftab Ahmad Khan , Muhammad Erfan Khattak, -
BENEFITS OF ASSISTED WEIGHT TRAINING IN PATIENTS WITH CHRONIC LOW BACK PAIN
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2024) / Melissa Alves Aires Marques, Bianca Gabriella De Oliveira, João Pedro Alves Xavier, Lucas Dias Borges Peres, Thaís Simões De Oliveira Borges, Hussien Ali Mustapha, Fabricio Negreiros Holtz, Ravi Cavalcanti Mendes, Marcella Rodrigues Costa Simões, -
ETIOPATOGENETIC FACTORS IN THE DEVELOPMENT OF PARODONTAL DISEASES IN POST-MENOPASIS WOMEN
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2022) / Nazarova Nodira Sharipovna, Islomova Nilufar Bustonovna, -
MORPHOLOGICAL AND FUNCTIONAL FACTORS OF PARODONTAL AND HARD TISSUES DISEASES
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2022) / Nazarova Nodira Sharipovna, Ruzimurodova Zilola Shukhratovna, -
EFFECTIVENESS OF EXERCISE PROGRAM ON LOW BACK PAIN AMONG NURSES WORKING AT A MEDICAL COLLEGE HOSPITAL IN DHAKA, BANGLADESH
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2023) / Halima Akter, Md. Shariful Islam, Jotsna Akter, Khaleda Akter,
References
D. P. Bicket, “Using ACE inhibitors appropriately,” American family physician, vol. 66, issue 3, pp. 461-8, 2002.
The Europa Trial Investigators, “Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery diseases: a randomised double blind, placebo controlled, multicenter trial (the EUROPA study),” The Lancet, vol. 362, issue 9, pages 782-88, 2003.
R. Ferrari, “Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized perindopril and remodeling in elderly with acute myocardial infarction (PREAMI) study,” Arch Intern Med, vol. 166, issue 6, pp. 659-66, 2006.
Management of Chronic Kidney Disease in Adults, 2nd ed., Ministry of Health., Putrajaya., WP, 2018.
Hypertension in Adults: diagnosis and management, National Institute for Health and Clinical Excellence., 2011.
Chronic kidney disease in adults: assessment and management, National Institute for Health and Clinical Excellence., 2014.
M. Schmidt, K. E. Mansfield, K. Bhaskaran, D. Nitsch, H. T. Sørensen, L. Smeeth, L. A. Tomlinson, “Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study,” BMJ Open, 2017.
J. S. Hurley, M. Roberts, L. I. Solberg, M. J. Gunter, W. W. Nelson, L. Young, F. J. Frost, “Laboratory safety monitoring of chronic medications in ambulatory care settings,” J Gen Intern Med, vol. 20, issue 4, pages 331-333, 2005.
J. E. Bootsma, M. F. W. Herwaarden, A. L. M. Verbeek, P. Füssenich, P. A. G. M. D. Smet, M. G. O. Rikkert, C. Kramers, “Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands,” Drug Saf, vol. 34, issue 7, pages 605-14, 2011.
G. L. Bakris, M. R. Weir, “ Angiotensin-converting enzyme inhibitor– associated elevations in serum creatinine: is this a cause for concern?,” Arch Intern Med., vol. 160, issue 5, pages 685-93, 2000.
